Juno Therapeutics CAR-T JCAR015 trial – how you can meet them this November

In early July 2016, Juno Therapeutics stock value plummeted by an unprecedented 27% after three patients died in a clinical trial testing their lead cancer therapy. After this, US regulators put this trial on pause, causing questions to be asked about the safety of the new approaches to battling cancer. The trial in question was being tested on adults with …